233 related articles for article (PubMed ID: 8996469)
1. Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies.
Bootsma H; Spronk PE; Hummel EJ; de Boer G; ter Borg EJ; Limburg PC; Kallenberg CG
Scand J Rheumatol; 1996; 25(6):352-9. PubMed ID: 8996469
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.
Bootsma H; Spronk PE; Ter Borg EJ; Hummel EJ; de Boer G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1997 Nov; 56(11):661-6. PubMed ID: 9462168
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test.
Werle E; Blazek M; Fiehn W
Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D;
Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Förger F; Matthias T; Oppermann M; Becker H; Helmke K
Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
Kim KH; Han JY; Kim JM; Lee SW; Chung WT
Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
[TBL] [Abstract][Full Text] [Related]
7. Comparison and evaluation of different methodologies and tests for detection of anti-dsDNA antibodies on 889 Slovenian patients' and blood donors' sera.
Zigon P; Lakota K; Cucnik S; Svec T; Ambrozic A; Sodin-Semrl S; Kveder T
Croat Med J; 2011 Dec; 52(6):694-702. PubMed ID: 22180268
[TBL] [Abstract][Full Text] [Related]
8. [Detection of dsDNA antibodies in diagnosis of systemic lupus erythematosus--comparative studies of diagnostic effectiveness of 3 ELISA methods with different antigens and a Crithidia luciliae immunofluorescence test].
Wigand R; Gottschalk R; Falkenbach A; Matthias T; Kaltwasser JP; Hoelzer D
Z Rheumatol; 1997; 56(2):53-62. PubMed ID: 9235810
[TBL] [Abstract][Full Text] [Related]
9. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
10. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS
J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230
[TBL] [Abstract][Full Text] [Related]
11. Anti-DNA antibodies: the choice of assays for routine diagnostic work.
Sarvas H; Gripenberg M; Leirisalo-Repo M
Acta Pathol Microbiol Immunol Scand C; 1985 Feb; 93(1):13-8. PubMed ID: 3885680
[TBL] [Abstract][Full Text] [Related]
12. [Detection of anti-double stranded DNA antibodies of IgG, IgA and IgM classes by ELISA. Comparison with the Farr test and indirect immunofluorescence].
Preud'homme JL; Danon F; Rochard E; Gouet D; Touchard G; Aucouturier P; Alcalay M
Presse Med; 1988 Jul 9-16; 17(27):1401-4. PubMed ID: 2971167
[TBL] [Abstract][Full Text] [Related]
13. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
14. Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus.
Biesen R; Dähnrich C; Rosemann A; Barkhudarova F; Rose T; Jakob O; Bruns A; Backhaus M; Stöcker W; Burmester GR; Schlumberger W; Egerer K; Hiepe F
Arthritis Res Ther; 2011 Feb; 13(1):R26. PubMed ID: 21329504
[TBL] [Abstract][Full Text] [Related]
15. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
[TBL] [Abstract][Full Text] [Related]
16. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.
Neogi T; Gladman DD; Ibanez D; Urowitz M
J Rheumatol; 2006 Sep; 33(9):1785-8. PubMed ID: 16924691
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
[TBL] [Abstract][Full Text] [Related]
18. Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Guialis A; Tzioufas G; Moutsopoulos HM
Br J Rheumatol; 1996 Jun; 35(6):534-41. PubMed ID: 8670573
[TBL] [Abstract][Full Text] [Related]
19. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
20. Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.
ter Borg EJ; Horst G; Hummel E; Limburg PC; Kallenberg CG
Clin Immunol Immunopathol; 1991 Apr; 59(1):117-28. PubMed ID: 2019007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
